News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Foto del Dr. Hugo Arasanz Esteban y de Dra. Laura Nevola
IDP Pharma begins clinical trial for its drug IDP-121 in patients with small-cell lung cancer
Healthcare · Drug discovery · Innovative drugs
The company IDP Pharma has initiated a Phase 1b/2 clinical trial for its drug candidate IDP-121,…
Logo Atlas Molecular Pharma
Atlas Molecular Pharma Announces First Three Patients with Congenital Erythropoietic Porphyria Dosed with ATL-001
Healthcare · Rare diseases · Innovative drugs
On October 19, 2026, the first patients in the Phase 1/2 clinical trial ATL001-PII-CEP received…
Biotecnología_edición_genética_plantas
AseBio calls for a science-based, proportionate European regulatory framework for new genomic techniques that fosters innovation
Agrifood · Agriculture · Gene editing · EU projects
We have submitted our contributions to the European Commission on the forthcoming delegated and…
Carlos Manuel Sousa Monagas, partner de NegotiumBio
#NewAseBioMember | "For us, AseBio represents much more than an industry association"
Corporate
Meet our new AseBio member NegotiumBio. We spoke with Carlos Manuel Sousa Monagas,…
Foto del medicamento Stablepharma-SPVX02
TIME Names Stablepharma's Fridge-Free Vaccine a best invention of 2026
Healthcare · Access to innovation · Innovative drugs
SPVX02 recognised in TIME's Medical & Healthcare category as Stablepharma advances its…
ORYZON anuncia sus resultados y avances en el  primer trimestre de 2026
ORYZON further strengthens vafidemstat’s patent portfolio with new decisions to grant
Healthcare · Innovative drugs · International
New patent allowances in South Korea, Mexico, New Zealand and the Philippines.
Científicos liofilizando en su planta de Boecillo
Spain’s 53Biologics announces over €2m expansion to tackle high-demand stabilisation of next-gen therapeutics
Healthcare · Innovative drugs
New freeze-drying (lyophilisation) capability at Boecillo site, strengthens 53Biologics’ position…
Simon Dew, nuevo director de Desarrollo de Negocio - Integra Therapeutics
Integra Therapeutics strengthens executive leadership with the appointment of Simon Dew as Chief Business Officer
Healthcare · Advanced therapies · Talento
Simon brings more than 20 years of experience in the biopharmaceutical industry, with a strong…
Entrada en el BEC, Bilbao, de BIOSPAIN 2026.
AseBio opens the call for applications to select the host cities for BIOSPAIN 2028 and 2030
BioSpain
Cities and organisations interested in hosting the event can submit their applications until 20…